Private company

Aridis Pharmaceuticals, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address983 University Avenue, Bldg. B, Los Gatos, Ca 950322
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-970.3%Operating margin3
-982.6%Net margin3
101.4%Revenue growth, 20223
-$29.2MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development100¢$25.9M

Out of $3.1M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$3.1M in 2022+259% since 2017
0$1.0M$2.0M$3.0M$4.0M2017: $860.0K$860.0K20172018: $2.8M$2.8M2018+221%2019: $1.0M$1.0M2019−63%2020: $1.0M$1.0M2020−2%2021: $1.5M$1.5M2021+53%2022: $3.1M$3.1M2022+101%
Operating income45673-$30.0M in 2022+52% since 2017
-$60.0M-$40.0M-$20.0M02017: -$19.7M-$19.7M20172018: -$24.1M-$24.1M2018+22%2019: -$29.1M-$29.1M2019+21%2020: -$22.4M-$22.4M2020−23%2021: -$42.7M-$42.7M2021+91%2022: -$30.0M-$30.0M2022−30%
Net income45673-$30.4M in 2022+23% since 2017
-$60.0M-$40.0M-$20.0M02017: -$24.7M-$24.7M20172018: -$22.1M-$22.1M2018−10%2019: -$29.7M-$29.7M2019+34%2020: -$22.3M-$22.3M2020−25%2021: -$42.2M-$42.2M2021+89%2022: -$30.4M-$30.4M2022−28%
Fiscal year2016201720182019202020212022
Revenue$860.0K4$2.8M5$1.0M6$1.0M7$1.5M3$3.1M3
Research and development$17.4M4$23.0M5$24.1M6$17.0M7$36.9M3$25.9M3
Operating income-$19.7M4-$24.1M5-$29.1M6-$22.4M7-$42.7M3-$30.0M3
Net income-$24.7M4-$22.1M5-$29.7M6-$22.3M7-$42.2M3-$30.4M3
Earnings per share-$164.984-$7.454-$2.447-$3.773-$1.623
Earnings per share (diluted)-$164.984-$7.454-$2.447-$3.777

Compare Aridis Pharmaceuticals, Inc. with another company

Recent filings

  1. Jun 28, 20244
  2. Jun 28, 20244
  3. Jun 28, 20244
  4. Jun 28, 20244
  5. Jun 28, 20244
  6. Jun 27, 20248-K
  7. Jan 16, 20248-K
  8. Dec 18, 20238-K
  9. Nov 6, 202310-Q
  10. Nov 3, 2023DEF 14A
  11. Nov 3, 20238-K
  12. Sep 19, 20234
  13. Sep 19, 20234
  14. Sep 19, 20234
  15. Sep 19, 20234

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1